At-Home Disposal Kits Increase Self-Disposal Rates of Opioids
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 10, 2025 -- Providing surgery patients with an opioid disposal kit at the time of discharge increases their self-disposal rates, according to a short report published online Jan. 1 in BMJ Open Quality.
Eric Shan, from the University of Pennsylvania in Philadelphia, and colleagues assessed the impact of opioid disposal kits on disposal rates after orthopedic surgery. The analysis included 1,321 eligible patients; comparisons were made for patients undergoing hip or knee arthroplasty from May to July 2022 versus July to September 2022 (when opioid disposal kits were provided at discharge).
The researchers found that disposal kits were associated with a 10.6 percentage point increase in disposal rates (20.8 to 28.4 percent) and a 10.5 percentage point increase in the fraction of opioids disposed (16.1 to 20.2 percent). The disposal kits were also found to be cost-effective, as each kit was valued at under $2.00.
"Any time we can cut down the number of opioids that could potentially circulate or be misused, it's a positive step," co-corresponding author Anish Agarwal, M.D., M.P.H., of the Center for Insights to Outcomes at the University of Pennsylvania Perelman School of Medicine, said in a statement. "If you can make the right decision the easy one, you're much more likely to get a positive outcome, and I think that's what we saw here."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-11 12:00
Read more
- FDA Approves Generic GLP-1 Medicine, Liraglutide, (a Victoza Generic), For Diabetes Treatment
- Could AI Plus Lasers Help Catch Very Early Breast Cancers?
- Position Statement Developed for Managing Blood Cancers in Pregnancy
- Decrease Seen in In Situ Breast Cancer Since 2009
- Neurological Outcomes Worsen With Gestational HTN, Preeclampsia, Eclampsia
- DoxyPEP Lowers Rate of Sexually Transmitted Infections (STIs), Data Suggests
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions